{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:10:27Z","timestamp":1792123827703,"version":"4.4.0"},"reference-count":268,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015257","name":"Northeastern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016980","name":"Otsuka Toshimi Scholarship Foundation","doi-asserted-by":"publisher","award":["17K08487"],"award-info":[{"award-number":["17K08487"]}],"id":[{"id":"10.13039\/100016980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016980","name":"Otsuka Toshimi Scholarship Foundation","doi-asserted-by":"publisher","award":["26640024"],"award-info":[{"award-number":["26640024"]}],"id":[{"id":"10.13039\/100016980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.neuropharm.2020.107969","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T02:01:30Z","timestamp":1579485690000},"page":"107969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Therapeutic potential of serotonin 4 receptor for chronic depression and its associated comorbidity in the gut"],"prefix":"10.1016","volume":"166","author":[{"given":"Lokesh","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9095-6377","authenticated-orcid":false,"given":"Mustafa","family":"Korkutata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Kumar","family":"Vimal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8594-6000","authenticated-orcid":false,"given":"Sanjib","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.107969_bib1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/BF01297028","article-title":"Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility","volume":"36","author":"Abell","year":"1991","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib2","doi-asserted-by":"crossref","first-page":"107712","DOI":"10.1016\/j.neuropharm.2019.107712","article-title":"Role of serotonin 4 receptor in the growth of hippocampal neurons during the embryonic development in mice","volume":"158","author":"Agrawal","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib3","first-page":"478","article-title":"Dysthymia in neurological disorders","volume":"1","author":"Akiskal","year":"1996","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107969_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s000110050301","article-title":"Effects of cinitapride on gastric ulceration and secretion in rats","volume":"47","author":"Alarcon de la Lastra","year":"1998","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.neuropharm.2020.107969_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/BF01320319","article-title":"Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility","volume":"31","author":"Alphin","year":"1986","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ddrr.15","article-title":"The nervous system and gastrointestinal function","volume":"14","author":"Altaf","year":"2008","journal-title":"Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.neuropharm.2020.107969_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuropharm.2016.08.037","article-title":"The absence of 5-HT4 receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: adaptive changes in hippocampal neuroplasticity markers and 5-HT1A autoreceptor","volume":"111","author":"Amigo","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib8","series-title":"Animal Models in Psychiatry, II","first-page":"1","article-title":"Multisystem regulation of performance deficits induced by stressors","author":"Anisman","year":"1992"},{"key":"10.1016\/j.neuropharm.2020.107969_bib9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.1101678","article-title":"Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice","volume":"306","author":"Ansorge","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.107969_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0893-133X(94)00094-G","article-title":"Neurochemical and physiological effects of cocaine oscillate with sequential drug treatment: possibly a major factor in drug variability","volume":"12","author":"Antelman","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib11","first-page":"61","article-title":"Diagnostic and statistical manual of mental disorders (DSM-5)","volume":"51","year":"2015","journal-title":"Alcohol. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2020.107969_bib12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0166-2236(96)10037-0","article-title":"Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists","volume":"19","author":"Artigas","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jgh.12662","article-title":"Mosapride treatment for functional dyspepsia: a meta-analysis","volume":"30","author":"Bang","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ibror.2018.11.008","article-title":"The human hypothalamus in mood disorders: the HPA axis in the center","volume":"6","author":"Bao","year":"2019","journal-title":"IBRO Rep."},{"key":"10.1016\/j.neuropharm.2020.107969_bib15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neuropharm.2017.08.031","article-title":"Chronic treatments with a 5-HT4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease","volume":"126","author":"Baranger","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib16","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1021\/jm0509501","article-title":"Pyrrolizidine esters and amides as 5-HT4 receptor agonists and antagonists","volume":"49","author":"Becker","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.107969_bib17","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ijnp\/pyx056","article-title":"Dopamine system dysregulation in major depressive disorders","volume":"20","author":"Belujon","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0893-133X(99)00076-7","article-title":"Modulation of the extracellular 5-hydroxytryptamine brain concentrations by the serotonin and noradrenaline reuptake inhibitor, milnacipran microdialysis studies in rats","volume":"21","author":"Bel","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.31887\/DCNS.2006.8.2\/fbenazzi","article-title":"Various forms of depression","volume":"8","author":"Benazzi","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/gut.47.5.667","article-title":"Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans","volume":"47","author":"Bharucha","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2020.107969_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.bjp.0702163","article-title":"The 5-HT4 receptor antagonist ML10375 inhibits the constitutive activity of human 5-HT4(c) receptor","volume":"125","author":"Blondel","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1568007043482615","article-title":"5-HT4 receptors","volume":"3","author":"Bockaert","year":"2004","journal-title":"Curr. Drug Targets - CNS Neurol. Disord."},{"key":"10.1016\/j.neuropharm.2020.107969_bib23","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.neuropharm.2008.05.013","article-title":"5-HT(4) receptors: history, molecular pharmacology and brain functions","volume":"55","author":"Bockaert","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib24","series-title":"5-HT4 Receptors in the Brain and Periphery","first-page":"63","article-title":"Localization of 5-HT4 receptors in vertebrate brain and their potential behavioral roles","author":"Bockaert","year":"1998"},{"key":"10.1016\/j.neuropharm.2020.107969_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1476-5381.1964.tb01563.x","article-title":"Obsdrvaions on the significance of 5-hydroxytryptamine in relation to the peristaltic reflex of the rat","volume":"23","author":"Boullin","year":"1964","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.neuropharm.2020.107969_bib26","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s00210-004-0919-4","article-title":"Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i)","volume":"369","author":"Brattelid","year":"2004","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1176\/ajp.157.1.115","article-title":"Hippocampal volume reduction in major depression","volume":"157","author":"Bremner","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107969_bib28","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1021\/acschemneuro.7b00026","article-title":"Serotonin and serotonin transporters in the adrenal Mmedulla: a potential hub for modulation of the sympathetic stress response","volume":"8","author":"Brindley","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01245227","article-title":"Dopamine and depression","volume":"91","author":"Brown","year":"1993","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"10.1016\/j.neuropharm.2020.107969_bib30","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.gastro.2016.10.046","article-title":"The vagus nerve in appetite regulation, mood, and intestinal inflammation","volume":"152","author":"Browning","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0165-0327(98)00163-3","article-title":"Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas","volume":"52","author":"Brunello","year":"1999","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2020.107969_bib32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tcm.2015.05.001","article-title":"Stress-induced cardiac arrhythmias: the heart-brain interaction","volume":"26","author":"Buckley","year":"2016","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.neuropharm.2020.107969_bib33","first-page":"26","article-title":"An investigation of the peristaltic reflex in relation to anatomical observations","volume":"43","author":"Bulbring","year":"1958","journal-title":"Q. J. Exp. Physiol. Cogn. Med. Sci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2174\/156802610791111551","article-title":"Review of 5-HT4R ligands: state of art and clinical applications","volume":"10","author":"Bureau","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.107969_bib35","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1592\/phco.24.5.526.33351","article-title":"Tegaserod-induced myocardial infarction: case report and hypothesis","volume":"24","author":"Busti","year":"2004","journal-title":"Pharmacother.: J. Hum. Pharmacol. Drug Ther."},{"key":"10.1016\/j.neuropharm.2020.107969_bib36","first-page":"77","article-title":"The role of serotonin receptors in Alzheimer's disease","volume":"2","author":"Butzlaff","year":"2016","journal-title":"Opera Med. Physiol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib37","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/MPG.0b013e31823d34c3","article-title":"Brain-gut axis: from basic understanding to treatment of IBS and related disorders","volume":"54","author":"Camilleri","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.neuropharm.2020.107969_bib38","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMoa0800670","article-title":"A placebo-controlled trial of prucalopride for severe chronic constipation","volume":"358","author":"Camilleri","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2020.107969_bib39","first-page":"704","article-title":"Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction","volume":"96","author":"Camilleri","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/0269881116677104","article-title":"The serotonin 5-HT(2C) receptor and the non-addictive nature of classic hallucinogens","volume":"31","author":"Canal","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0091-3057(01)00535-4","article-title":"R-zacopride, a 5-HT3 antagonist\/5-HT4 agonist, reduces sleep apneas in rats","volume":"69","author":"Carley","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2020.107969_bib42","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/01.psy.0000162254.61556.d5","article-title":"Depression, the autonomic nervous system, and coronary heart disease","volume":"67","author":"Carney","year":"2005","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.neuropharm.2020.107969_bib43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuint.2019.01.019","article-title":"Neurochemical impact of the 5-HT2C receptor agonist WAY-163909 on monoamine tissue content in the rat brain","volume":"124","author":"Chagraoui","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2020.107969_bib44","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/nmo.12544","article-title":"Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial","volume":"27","author":"Choi","year":"2015","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2020.107969_bib45","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3892\/etm.2017.4185","article-title":"Prokinetic effects of LD02GIFRO on functional gastrointestinal disorder in rats","volume":"13","author":"Choi","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.neuropharm.2020.107969_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00250","article-title":"5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders","volume":"8","author":"Ciranna","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1749-6632.1998.tb10172.x","article-title":"5-HT4 receptors: cloning and expression of new splice variants","volume":"861","author":"Claeysen","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib48","first-page":"170","article-title":"The 5-HT1B receptor: behavioral implications","volume":"35","author":"Clark","year":"2001","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.neuropharm.2020.107969_bib49","series-title":"5-HT4 Receptors in the Brain and Periphery","first-page":"1","article-title":"Medicinal chemistry of 5-HT4 receptor ligands","author":"Clark","year":"1998"},{"key":"10.1016\/j.neuropharm.2020.107969_bib50","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1021\/cn300095t","article-title":"5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10","volume":"4","author":"Cochet","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib51","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1460-9568.2006.04943.x","article-title":"Adaptive changes in serotonin neurons of the raphe nuclei in 5-HT(4) receptor knock-out mouse","volume":"24","author":"Conductier","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib52","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/00001756-199406020-00018","article-title":"5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex","volume":"5","author":"Consolo","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2020.107969_bib53","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1139\/y00-098","article-title":"Role of 5-HT in the regulation of the brain-pituitary-adrenal axis: effects of 5-HT on adrenocortical cells","volume":"78","author":"Contesse","year":"2000","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib54","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/archpsyc.1972.01750230084016","article-title":"Abnormalities of indoleamines in affective disorders","volume":"26","author":"Coppen","year":"1972","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107969_bib55","first-page":"45","article-title":"Prucalopride: the evidence for its use in the treatment of chronic constipation","volume":"3","author":"Coremans","year":"2008","journal-title":"Core Evid."},{"key":"10.1016\/j.neuropharm.2020.107969_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020336","article-title":"Insights into the molecular mechanisms of Alzheimer's and Parkinson's diseases with molecular simulations: understanding the roles of artificial and pathological missense mutations in intrinsically disordered proteins related to pathology","volume":"19","author":"Coskuner-Weber","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib57","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.2042-7158.1988.tb05254.x","article-title":"Zacopride: anxiolytic profile in rodent and primate models of anxiety","volume":"40","author":"Costall","year":"1988","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib58","doi-asserted-by":"crossref","first-page":"13525","DOI":"10.1073\/pnas.2233056100","article-title":"Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function","volume":"100","author":"Cote","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.107969_bib59","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2174\/157015907782793621","article-title":"Human 5-HT(4) and 5-HT(7) receptor splice variants: are they important?","volume":"5","author":"Coupar","year":"2007","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib60","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/sj.bjp.0705762","article-title":"Role of serotonin in the pathophysiology of the irritable bowel syndrome","volume":"141","author":"Crowell","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib61","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2015.07.001","article-title":"Major depressive disorder: understanding the significance of residual symptoms and balancing efficacy with tolerability","volume":"128","author":"Culpepper","year":"2015","journal-title":"Am. J. Med."},{"key":"10.1016\/j.neuropharm.2020.107969_bib62","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1017\/S1092852915000425","article-title":"Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function","volume":"21","author":"Dale","year":"2016","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2020.107969_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2982.2007.01059.x","article-title":"5-HT4 receptor agonists: similar but not the same","volume":"20","author":"De Maeyer","year":"2008","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2020.107969_bib64","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bjp.0702572","article-title":"Investigation of the role of 5-HT1B and 5-HT1D receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses","volume":"127","author":"De Vries","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib65","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2015.11.009","article-title":"New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders","volume":"157","author":"Di Giovanni","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2020.107969_bib66","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/mp.2011.159","article-title":"5-HT(2B) receptors are required for serotonin-selective antidepressant actions","volume":"17","author":"Diaz","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107969_bib67","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0026-895X(25)10130-2","article-title":"A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system","volume":"34","author":"Dumuis","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib68","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1476-5381.1993.tb12812.x","article-title":"The action of SDZ 205,557 at 5-hydroxytryptamine (5-HT3 and 5-HT4) receptors","volume":"108","author":"Eglen","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib69","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1476-5381.1992.tb09087.x","article-title":"The 5-HT4 receptor subtype inhibits K+ current in colliculi neurones via activation of a cyclic AMP-dependent protein kinase","volume":"105","author":"Fagni","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib70","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0361-9230(87)90186-9","article-title":"Paraventricular nucleus serotonin mediates neurally stimulated adrenocortical secretion","volume":"18","author":"Feldman","year":"1987","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2020.107969_bib71","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/BF01291881","article-title":"Hypothalamic mechanisms mediating glutamate effects on the hypothalamo-pituitary-adrenocortical axis","volume":"104","author":"Feldman","year":"1997","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuropharm.2020.107969_bib72","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0361-9230(97)00384-5","article-title":"The excitatory effects of the amygdala on hypothalamo-pituitary-adrenocortical responses are mediated by hypothalamic norepinephrine, serotonin, and CRF-41","volume":"45","author":"Feldman","year":"1998","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2020.107969_bib73","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0028-3908(97)00055-5","article-title":"The effects of novel, selective 5-hydroxytryptamine (5-HT) 4 receptor ligands in rat spatial navigation","volume":"36","author":"Fontana","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib74","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","article-title":"Gut\u2013brain axis: how the microbiome influences anxiety and depression","volume":"36","author":"Foster","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib75","doi-asserted-by":"crossref","first-page":"9446","DOI":"10.1021\/jm300573d","article-title":"Discovery and pharmacological profile of new 1H-indazole-3-carboxamide and 2H-pyrrolo[3,4-c]quinoline derivatives as selective serotonin 4 receptor ligands","volume":"55","author":"Furlotti","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.107969_bib76","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrgastro.2012.32","article-title":"The enteric nervous system and neurogastroenterology","volume":"9","author":"Furness","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib77","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1476-5381.1994.tb14064.x","article-title":"GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor","volume":"111","author":"Gale","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib78","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00213-013-3389-x","article-title":"5-HT(1A) [corrected] receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function","volume":"231","author":"Garcia-Garcia","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib79","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1038\/s41598-019-40566-x","article-title":"Dysregulation of the hypothalamic pituitary adrenal (HPA) axis and cognitive capability at older ages: individual participant meta-analysis of five cohorts","volume":"9","author":"Gardner","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2020.107969_bib80","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/(SICI)1098-1128(199703)17:2<163::AID-MED2>3.0.CO;2-Y","article-title":"Serotonin 5-HT3 and 5-HT4 receptor antagonists","volume":"17","author":"Gaster","year":"1997","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuropharm.2020.107969_bib81","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2005.08.020","article-title":"Influence of experimentally induced anxiety on gastric sensorimotor function in humans","volume":"129","author":"Geeraerts","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib82","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3758\/s13415-017-0552-6","article-title":"Dorsomedial prefrontal cortex 5-HT6 receptors regulate anxiety-like behavior","volume":"18","author":"Geng","year":"2018","journal-title":"Cognit. Affect Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib83","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2004.02180.x","article-title":"Review article: serotonin receptors and transporters \u2014 roles in normal and abnormal gastrointestinal motility","volume":"20","author":"Gershon","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2020.107969_bib84","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MED.0b013e32835bc703","article-title":"5-Hydroxytryptamine (serotonin) in the gastrointestinal tract","volume":"20","author":"Gershon","year":"2013","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.neuropharm.2020.107969_bib85","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","article-title":"The serotonin signaling system: from basic understanding to drug development for functional GI disorders","volume":"132","author":"Gershon","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib86","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fnagi.2013.00096","article-title":"Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease","volume":"5","author":"Giannoni","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib87","first-page":"37","article-title":"Cranial nerves IX, X, XI, and XII","volume":"7","author":"Gillig","year":"2010","journal-title":"Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107969_bib88","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0707253","article-title":"Tricyclic antidepressant pharmacology and therapeutic drug interactions updated","volume":"151","author":"Gillman","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib89","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bbr.2013.05.051","article-title":"Role of 5-HT5A receptors in the consolidation of memory","volume":"252","author":"Gonzalez","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.107969_bib90","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-2999(01)00933-5","article-title":"Human 5-HT5 receptors: the 5-HT5A receptor is functional but the 5-HT5B receptor was lost during mammalian evolution","volume":"418","author":"Grailhe","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2020.107969_bib91","first-page":"145","article-title":"Neuropharmacology of 5-hydroxytryptamine","volume":"147","author":"Green","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib92","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1124\/jpet.103.053512","article-title":"Neurotransmitters mediating the intestinal peristaltic reflex in the mouse","volume":"307","author":"Grider","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2020.107969_bib93","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/sj.mp.4000697","article-title":"Dysthymia: a review of pharmacological and behavioral factors","volume":"5","author":"Griffiths","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107969_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2015.00046","article-title":"Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?","volume":"6","author":"Guiard","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib95","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1002\/hbm.22123","article-title":"The 5-HT4 receptor levels in hippocampus correlates inversely with memory test performance in humans","volume":"34","author":"Haahr","year":"2013","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neuropharm.2020.107969_bib96","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.nlm.2016.06.014","article-title":"The serotonergic 5-HT4 receptor: a unique modulator of hippocampal synaptic information processing and cognition","volume":"138","author":"Hagena","year":"2017","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2020.107969_bib97","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1046\/j.1365-2036.2002.01236.x","article-title":"Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study","volume":"16","author":"Hallerback","year":"2002","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2020.107969_bib98","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.3748\/wjg.14.2639","article-title":"Updates on treatment of irritable bowel syndrome","volume":"14","author":"Hammerle","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib99","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2008.03.020","article-title":"Molecular biology of 5-HT receptors","volume":"195","author":"Hannon","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.107969_bib100","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/rheumatology\/35.2.112","article-title":"The role of endogenous serotonin in adjuvant-induced arthritis in the rat","volume":"35","author":"Harbuz","year":"1996","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib101","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/003655202317284192","article-title":"Are anxiety and depression related to gastrointestinal symptoms in the general population?","volume":"37","author":"Haug","year":"2002","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib102","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-009-1626-0","article-title":"The 5-HT7 receptor and disorders of the nervous system: an overview","volume":"206","author":"Hedlund","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib103","first-page":"1398","article-title":"Peripheral 5-HT4 receptors","volume":"10","author":"Hegde","year":"1996","journal-title":"FASEB (Fed. Am. Soc. Exp. Biol.) J."},{"key":"10.1016\/j.neuropharm.2020.107969_bib104","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yfrne.2003.07.001","article-title":"Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo\u2013pituitary\u2013adrenocortical responsiveness","volume":"24","author":"Herman","year":"2003","journal-title":"Front. Neuroendocrinol."},{"issue":"8","key":"10.1016\/j.neuropharm.2020.107969_bib268","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/mp.2017.147","article-title":"Efficacy of selective serotonin reuptake inhibitors in the absence of side effects: a mega-analysis of citalopram and paroxetine in adult depression.","volume":"23","author":"Hieronymus","year":"2018","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107969_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0038550","article-title":"A brief history of the development of antidepressant drugs: from monoamines to glutamate","volume":"23","author":"Hillhouse","year":"2015","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2020.107969_bib106","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1111\/j.1460-9568.2007.05547.x","article-title":"Serotonin increases the excitability of the hypothalamic paraventricular nucleus magnocellular neurons","volume":"25","author":"Ho","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib107","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1053\/j.gastro.2011.12.041","article-title":"Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity","volume":"142","author":"Hoffman","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib108","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.gastro.2004.01.006","article-title":"G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia","volume":"126","author":"Holtmann","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib109","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1046\/j.1365-2036.1999.00625.x","article-title":"5-HT4 receptor antagonism in irritable bowel syndrome: effect of SB-207266-A on rectal sensitivity and small bowel transit","volume":"13","author":"Houghton","year":"1999","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2020.107969_bib110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0006-3223(91)90112-Y","article-title":"Biological studies of dysthymia","volume":"30","author":"Howland","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107969_bib111","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1053\/j.gastro.2019.04.022","article-title":"Effects of serotonin and slow-release 5-hydroxytryptophan on gastrointestinal motility in a mouse model of depression","volume":"157","author":"Israelyan","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib112","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1023\/A:1021904216312","article-title":"Anxiety and depression are related to autonomic nervous system function in women with irritable bowel syndrome","volume":"48","author":"Jarrett","year":"2003","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib113","doi-asserted-by":"crossref","first-page":"16335","DOI":"10.1073\/pnas.0701471104","article-title":"Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens","volume":"104","author":"Jean","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib114","series-title":"Psychopharmacology: the Third Generation of Progress","first-page":"505","article-title":"Role of dopamine mechanisms in the affective disorders","author":"Jimerson","year":"1987"},{"key":"10.1016\/j.neuropharm.2020.107969_bib115","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1242\/jcs.01379","article-title":"New sorting nexin (SNX27) and NHERF specifically interact with the 5-HT4a receptor splice variant: roles in receptor targeting","volume":"117","author":"Joubert","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib116","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1046\/j.1365-2036.2000.00854.x","article-title":"The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease","volume":"14","author":"Kahrilas","year":"2000","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2020.107969_bib117","series-title":"Serotonin: from Cell Biology to Pharmacology and Therapeutics","first-page":"135","article-title":"SB 203186: a potent 5-HT4 antagonist for cardiac 5-HT4 receptors","author":"Kaumann","year":"1993"},{"key":"10.1016\/j.neuropharm.2020.107969_bib118","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1176\/ajp.139.4.438","article-title":"\u201cDouble depression\u201d: superimposition of acute depressive episodes on chronic depressive disorders","volume":"139","author":"Keller","year":"1982","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107969_bib119","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0028-3908(97)00037-3","article-title":"Anxiolytic-like actions of the selective 5-HT4 receptor antagonists SB 204070A and SB 207266A in rats","volume":"36","author":"Kennett","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1310\/sci2102-149","article-title":"Depression following spinal cord injury: its relationship to demographic and socioeconomic indicators","volume":"21","author":"Khazaeipour","year":"2015","journal-title":"Top. Spinal Cord Inj. Rehabil."},{"key":"10.1016\/j.neuropharm.2020.107969_bib121","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/eurjhf\/hfp087","article-title":"Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure","volume":"11","author":"Kjekshus","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.neuropharm.2020.107969_bib122","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0193-953X(05)70272-0","article-title":"Symptomatology in dysthymic and major depressive disorder","volume":"19","author":"Klein","year":"1996","journal-title":"Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.neuropharm.2020.107969_bib123","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1476-5381.2012.01868.x","article-title":"Distribution of 5-ht(1E) receptors in the mammalian brain and cerebral vasculature: an immunohistochemical and pharmacological study","volume":"166","author":"Klein","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib124","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1248\/bpb.30.508","article-title":"Pharmacological characterization of 5-hydroxytryptamine-receptor subtypes in circular muscle from the rat stomach","volume":"30","author":"Komada","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuropharm.2020.107969_bib125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainres.2016.11.021","article-title":"Roles of the serotonin 5-HT4 receptor in dendrite formation of the rat hippocampal neurons in vitro","volume":"1655","author":"Kozono","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.107969_bib126","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0306-4522(98)00369-8","article-title":"Involvement of serotonergic pathways in mediating the neuronal activity and genetic transcription of neuroendocrine corticotropin-releasing factor in the brain of systemically endotoxin-challenged rats","volume":"88","author":"Laflamme","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.107969_bib127","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4155\/fmc-2017-0031","article-title":"Modulating 5-HT4 and 5-HT6 receptors in Alzheimer's disease treatment","volume":"9","author":"Lalut","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.107969_bib128","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2014.00313","article-title":"CART in the regulation of appetite and energy homeostasis","volume":"8","author":"Lau","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib129","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1586\/eem.10.41","article-title":"Metoclopramide in the treatment of diabetic gastroparesis","volume":"5","author":"Lee","year":"2010","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2020.107969_bib130","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1210\/jcem.86.10.7917","article-title":"Production and metabolism of serotonin (5-HT) by the human adrenal cortex: paracrine stimulation of aldosterone secretion by 5-HT","volume":"86","author":"Lefebvre","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2020.107969_bib131","first-page":"1662","article-title":"Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex: in vivo and in vitro studies","volume":"77","author":"Lefebvre","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2020.107969_bib132","series-title":"5-HT4 Receptors in the Brain and Periphery","article-title":"The 5-HT4 receptor in the adrenal gland","author":"Lefebvre","year":"1998"},{"key":"10.1016\/j.neuropharm.2020.107969_bib133","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/j.1572-0241.1999.01009.x","article-title":"Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome","volume":"94","author":"Lembo","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib134","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.1523\/JNEUROSCI.6684-10.2011","article-title":"Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development\/survival of enteric dopaminergic neurons","volume":"31","author":"Li","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib135","doi-asserted-by":"crossref","first-page":"9683","DOI":"10.1523\/JNEUROSCI.1145-09.2009","article-title":"5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice","volume":"29","author":"Liu","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib136","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/mds.20387","article-title":"Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients","volume":"20","author":"Liu","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2020.107969_bib137","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2174\/1568026023393769","article-title":"5-HT4 receptor antagonists: structure-affinity relationships and ligand-receptor interactions","volume":"2","author":"Lopez-Rodriguez","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.107969_bib138","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1046\/j.1365-2826.2002.00861.x","article-title":"Functional subsets of serotonergic neurones: implications for control of the hypothalamic\u2010pituitary\u2010adrenal axis","volume":"14","author":"Lowry","year":"2002","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib139","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.neuron.2007.07.041","article-title":"Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action","volume":"55","author":"Lucas","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.107969_bib140","doi-asserted-by":"crossref","first-page":"40239","DOI":"10.1074\/jbc.R112.406496","article-title":"5-HT(3) receptors","volume":"287","author":"Lummis","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2020.107969_bib141","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.30.1_supplement.927.9","article-title":"The 5-HT4 receptor agonists prucalopride and BIMU8 suppress abdominal nociception in animal models","volume":"30","author":"Lyubashina","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2020.107969_bib142","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/archpsyc.1975.01760290025002","article-title":"Biogenic amines and depression: biochemical and pharmacological separation of two types of depression","volume":"32","author":"Maas","year":"1975","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107969_bib143","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2036.1991.tb00014.x","article-title":"The effects of renzapride, a novel prokinetic agent, in diabetic gastroparesis","volume":"5","author":"Mackie","year":"1991","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2020.107969_bib144","doi-asserted-by":"crossref","first-page":"pyu034","DOI":"10.1093\/ijnp\/pyu034","article-title":"Familial risk for major depression is associated with lower striatal 5-HT\u2084 receptor binding","volume":"18","author":"Madsen","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib145","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib146","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1517\/13543784.2010.482927","article-title":"New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders","volume":"19","author":"Manabe","year":"2010","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.neuropharm.2020.107969_bib147","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1126\/science.1084674","article-title":"5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia","volume":"301","author":"Manzke","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.107969_bib148","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.10094.1","article-title":"Understanding the role of serotonin in psychiatric diseases","volume":"6","author":"Marazziti","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.neuropharm.2020.107969_bib149","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2165\/11633130-000000000-00000","article-title":"Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date","volume":"72","author":"Mathews","year":"2012","journal-title":"Drugs"},{"issue":"Suppl. 8","key":"10.1016\/j.neuropharm.2020.107969_bib150","first-page":"28","article-title":"Depression, anxiety, and the gastrointestinal system","volume":"62","author":"Mayer","year":"2001","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107969_bib151","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-med-012309-103958","article-title":"The brain-gut axis in abdominal pain syndromes","volume":"62","author":"Mayer","year":"2011","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neuropharm.2020.107969_bib152","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1007\/BF00442554","article-title":"Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia","volume":"99","author":"Meltzer","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib153","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/npp.2013.332","article-title":"Rapid anxiolytic effects of a 5-HT\u2084 receptor agonist are mediated by a neurogenesis-independent mechanism","volume":"39","author":"Mendez-David","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib154","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2014.00207","article-title":"5-HT7 receptor stimulation and blockade: a therapeutic paradox about memory formation and amnesia","volume":"8","author":"Meneses","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib155","series-title":"The Role of 5-HT Systems on Memory and Dysfunctional Memory","first-page":"17","article-title":"Chapter 4 - 5-HT1A receptor","author":"Meneses","year":"2014"},{"key":"10.1016\/j.neuropharm.2020.107969_bib156","series-title":"The Role of 5-HT Systems on Memory and Dysfunctional Memory","first-page":"23","article-title":"Chapter 5 - 5-HT1B receptor","author":"Meneses","year":"2014"},{"key":"10.1016\/j.neuropharm.2020.107969_bib157","series-title":"The Role of 5-HT Systems on Memory and Dysfunctional Memory","first-page":"27","article-title":"Chapter 6 - 5-HT1E\/1F receptor","author":"Meneses","year":"2014"},{"key":"10.1016\/j.neuropharm.2020.107969_bib158","series-title":"The Role of 5-HT Systems on Memory and Dysfunctional Memory","first-page":"29","article-title":"Chapter 7 - 5-HT2A\/2B\/2C receptor","author":"Meneses","year":"2014"},{"key":"10.1016\/j.neuropharm.2020.107969_bib159","series-title":"The Role of 5-HT Systems on Memory and Dysfunctional Memory","first-page":"35","article-title":"Chapter 8 - 5-HT3 receptor","author":"Meneses","year":"2014"},{"key":"10.1016\/j.neuropharm.2020.107969_bib160","series-title":"The Role of 5-HT Systems on Memory and Dysfunctional Memory","first-page":"39","article-title":"Chapter 9 - 5-HT4 receptor","author":"Meneses","year":"2014"},{"key":"10.1016\/j.neuropharm.2020.107969_bib161","series-title":"The Role of 5-HT Systems on Memory and Dysfunctional Memory","first-page":"45","article-title":"Chapter 10 - 5-HT5 receptor","author":"Meneses","year":"2014"},{"key":"10.1016\/j.neuropharm.2020.107969_bib162","series-title":"The Role of 5-HT Systems on Memory and Dysfunctional Memory","first-page":"49","article-title":"Chapter 11 - 5-HT6 receptor","author":"Meneses","year":"2014"},{"key":"10.1016\/j.neuropharm.2020.107969_bib163","series-title":"The Role of 5-HT Systems on Memory and Dysfunctional Memory","first-page":"53","article-title":"Chapter 12 - 5-HT7 receptor","author":"Meneses","year":"2014"},{"key":"10.1016\/j.neuropharm.2020.107969_bib164","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0091-3057(96)00224-9","article-title":"Effects of 5-HT4 receptor agonists and antagonists in learning","volume":"56","author":"Meneses","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.107969_bib165","doi-asserted-by":"crossref","first-page":"R405","DOI":"10.1152\/ajpregu.00440.2005","article-title":"Zacopride and 8-OH-DPAT reverse opioid-induced respiratory depression and hypoxia but not catatonic immobilization in goats","volume":"290","author":"Meyer","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib166","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0014-2999(96)00974-0","article-title":"Antiemetic effects of N-3389, a newly synthesized 5-HT3 and 5-HT4 receptor antagonist, in ferrets","volume":"321","author":"Minami","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib167","first-page":"374","article-title":"Comparison of the effect of BRL 24924, metoclopramide and domperidone on cisplatin-induced emesis in the ferret","volume":"88","author":"Miner","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib168","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bjc.1987.177","article-title":"Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis","volume":"56","author":"Miner","year":"1987","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.neuropharm.2020.107969_bib169","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.neuropharm.2007.06.016","article-title":"VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux","volume":"53","author":"Mohler","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib170","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2015.00015","article-title":"Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities","volume":"6","author":"Moloney","year":"2015","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107969_bib171","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1192\/S0007125000298504","article-title":"Depression and endocrine disorders: focus on the thyroid and adrenal system","volume":"168","author":"Musselman","year":"1996","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107969_bib172","doi-asserted-by":"crossref","first-page":"123","DOI":"10.12688\/f1000research.9736.1","article-title":"Serotonin receptors in depression: from A to B","volume":"6","author":"Nautiyal","year":"2017","journal-title":"F1000 Res."},{"key":"10.1016\/j.neuropharm.2020.107969_bib173","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s13104-018-3495-2","article-title":"Effect of the 5-HT4 receptor agonist tegaserod on the expression of GRK2 and GRK6 in the rat gastrointestinal tract","volume":"11","author":"Nedi","year":"2018","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.neuropharm.2020.107969_bib174","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40263-015-0236-0","article-title":"Targeting the serotonin 5-HT7 receptor in the search for treatments for CNS disorders: rationale and progress to date","volume":"29","author":"Nikiforuk","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2020.107969_bib175","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/sj.mp.4001133","article-title":"Association between serotonin 4 receptor gene polymorphisms and bipolar disorder in Japanese case-control samples and the NIMH Genetics Initiative Bipolar Pedigrees","volume":"7","author":"Ohtsuki","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107969_bib176","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1101\/lm.67303","article-title":"Acquisition, retention, and recall of memory after injection of RS67333, a 5-HT(4) receptor agonist, into the nucleus basalis magnocellularis of the rat","volume":"10","author":"Orsetti","year":"2003","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2020.107969_bib177","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1074\/mcp.M112.025536","article-title":"A hybrid structural approach to analyze ligand binding by the serotonin type 4 receptor (5-HT4)","volume":"12","author":"Padayatti","year":"2013","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.neuropharm.2020.107969_bib178","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1159\/000126332","article-title":"Activation of 5-HT1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH and ACTH release in the rat","volume":"56","author":"Pan","year":"1992","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib179","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1007\/s10620-005-2860-x","article-title":"Increased beta-adrenergic sensitivity correlates with visceral hypersensitivity in patients with constipation-predominant irritable bowel syndrome","volume":"50","author":"Park","year":"2005","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib180","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/j.1572-0241.2002.05841.x","article-title":"Serotonin transporter gene polymorphism in irritable bowel syndrome","volume":"97","author":"Pata","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib181","first-page":"1","article-title":"Interactions between the endocrine system and the gastrointestinal tract","volume":"4","author":"Paz-Filho","year":"2014","journal-title":"Transl. Gastrointest. Cancer"},{"key":"10.1016\/j.neuropharm.2020.107969_bib182","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.gastrohep.2009.06.013","article-title":"Efficacy and tolerability of cinitapride in the treatment of functional dyspepsia and delayed gastric emptying","volume":"32","author":"Portincasa","year":"2009","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib183","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/gut.2003.017962","article-title":"Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress","volume":"53","author":"Posserud","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2020.107969_bib184","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0016-5085(00)70251-4","article-title":"Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome","volume":"118","author":"Prather","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib185","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2013.00873","article-title":"From weight loss to weight gain: appetite changes in major depressive disorder as a mirror into brain-environment interactions","volume":"4","author":"Privitera","year":"2013","journal-title":"Front. Psychol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib186","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejphar.2004.04.029","article-title":"The role of the 5-HT1D receptor as a presynaptic autoreceptor in the Guinea pig","volume":"493","author":"Pullar","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib187","doi-asserted-by":"crossref","first-page":"14126","DOI":"10.3748\/wjg.v20.i39.14126","article-title":"Impact of psychological stress on irritable bowel syndrome","volume":"20","author":"Qin","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib188","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1756283X11423706","article-title":"Prucalopride: safety, efficacy and potential applications","volume":"5","author":"Quigley","year":"2012","journal-title":"Ther. Adv. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib189","doi-asserted-by":"crossref","first-page":"330","DOI":"10.5056\/jnm15094","article-title":"Prokinetics in the management of functional gastrointestinal disorders","volume":"21","author":"Quigley","year":"2015","journal-title":"J. Neurogastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2020.107969_bib190","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2036.2008.03884.x","article-title":"Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation - a 12-week, randomized, double-blind, placebo-controlled study","volume":"29","author":"Quigley","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2020.107969_bib191","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1046\/j.1468-2982.2003.00525.x","article-title":"5-HT1F receptor agonists in acute migraine treatment: a hypothesis","volume":"23","author":"Ramadan","year":"2003","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuropharm.2020.107969_bib192","doi-asserted-by":"crossref","DOI":"10.1186\/alzrt169","article-title":"5-HT6 receptors and Alzheimer's disease","volume":"5","author":"Ram\u00edrez","year":"2013","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neuropharm.2020.107969_bib193","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrgastro.2016.107","article-title":"The bowel and beyond: the enteric nervous system in neurological disorders","volume":"13","author":"Rao","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib194","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrgastro.2017.85","article-title":"Neurogastroenterology: the dynamic cycle of life in the enteric nervous system","volume":"14","author":"Rao","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib195","series-title":"Frontiers in Neuroscience, Serotonin Receptors in Neurobiology","first-page":"1","article-title":"Serotonin 2A (5-HT2A) receptor function: ligand-dependent mechanisms and pathways","author":"Raote","year":"2007"},{"key":"10.1016\/j.neuropharm.2020.107969_bib196","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0021-9258(19)51208-X","article-title":"Serum vasoconstrictor (serotonin) the presence of creatinine in the complex; a proposed structure of the vasoconstrictor principle","volume":"180","author":"Rapport","year":"1949","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2020.107969_bib197","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000070579","article-title":"Depressed patients have higher body temperature: 5-HT transporter long promoter region effects","volume":"47","author":"Rausch","year":"2003","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib198","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2008.11.056","article-title":"Identification of a novel 5-HT4 receptor splice variant (r5-HT4c1) and preliminary characterisation of specific 5-HT4a and 5-HT4b receptor antibodies","volume":"604","author":"Ray","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib199","doi-asserted-by":"crossref","first-page":"E3581","DOI":"10.3390\/ijms19113581","article-title":"Alterations of expression of the serotonin 5-HT4 receptor in brain disorders","volume":"19","author":"Rebholz","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib200","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1476-5381.1995.tb13303.x","article-title":"5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases","volume":"114","author":"Reynolds","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib201","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuron.2009.12.003","article-title":"5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants","volume":"65","author":"Richardson-Jones","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.107969_bib202","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000077365","article-title":"Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suicide victims","volume":"49","author":"Rosel","year":"2004","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib203","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0014-2999(69)90091-0","article-title":"Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue","volume":"7","author":"Ross","year":"1969","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib204","first-page":"10","article-title":"Depression increases the risk for uncontrolled hypertension","volume":"18","author":"Rubio-Guerra","year":"2013","journal-title":"Exp. Clin. Cardiol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib205","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/gut.2003.018911","article-title":"Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome","volume":"53","author":"Sagami","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2020.107969_bib206","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-230X-12-42","article-title":"Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS)","volume":"12","author":"Sakurai","year":"2012","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib207","doi-asserted-by":"crossref","first-page":"E853","DOI":"10.1152\/ajpendo.00772.2007","article-title":"The selective serotonin reuptake inhibitor sertraline enhances counterregulatory responses to hypoglycemia","volume":"294","author":"Sanders","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib208","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1476-5381.1987.tb08985.x","article-title":"Increased gut cholinergic activity and antagonism of 5\u2010hydroxytryptamine M\u2010receptors by BRL 24924: potential clinical importance of BRL 24924","volume":"91","author":"Sanger","year":"1987","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib209","doi-asserted-by":"crossref","first-page":"S4136","DOI":"10.4137\/CGast.S4136","article-title":"Constipation, IBs and the 5-HT4 Receptor: what role for prucalopride?","volume":"3","author":"Sanger","year":"2010","journal-title":"Clin. Med. Gastroenterol."},{"issue":"5","key":"10.1016\/j.neuropharm.2020.107969_bib210","first-page":"46","article-title":"Dysthymic disorder: forlorn and overlooked?","volume":"6","author":"Sansone","year":"2009","journal-title":"Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107969_bib211","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12888-017-1551-4","article-title":"The association between electrodermal activity (EDA), depression and suicidal behaviour: a systematic review and narrative synthesis","volume":"18","author":"Sarchiapone","year":"2018","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107969_bib212","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0300-9629(97)00026-1","article-title":"Nitric oxide and the digestive system in mammals and non-mammalian vertebrates","volume":"118","author":"Schleiffer","year":"1997","journal-title":"Comp. Biochem. Physiol. Physiol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib213","first-page":"224","article-title":"Psychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence?","volume":"27","author":"Shah","year":"2014","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib214","series-title":"Psychopharmacology: the Third Generation of Progress","first-page":"493","article-title":"Role of noradrenergic mechanisms in the etiology of the affective disorders","author":"Siever","year":"1987"},{"key":"10.1016\/j.neuropharm.2020.107969_bib215","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1176\/appi.ajp.2015.15020162","article-title":"Depression-related increases and decreases in appetite: dissociable patterns of aberrant activity in reward and interoceptive neurocircuitry","volume":"173","author":"Simmons","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107969_bib216","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00001756-199902250-00019","article-title":"5-HT4 receptor modulation of acetylcholine outflow in Guinea pig brain slices","volume":"10","author":"Siniscalchi","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2020.107969_bib217","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0166-4328(96)00089-7","article-title":"GR127935: a potent and selective 5-HT1D receptor antagonist","volume":"73","author":"Skingle","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.107969_bib218","doi-asserted-by":"crossref","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress","volume":"8","author":"Smith","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib219","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.2042-7158.1989.tb06402.x","article-title":"The antiemetic profile of zacopride","volume":"41","author":"Smith","year":"1989","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib220","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2220\/biomedres.28.85","article-title":"Oral treatment with L-lysine and L-arginine reduces anxiety and basal cortisol levels in healthy humans","volume":"28","author":"Smriga","year":"2007","journal-title":"Biomed. Res."},{"key":"10.1016\/j.neuropharm.2020.107969_bib221","doi-asserted-by":"crossref","first-page":"15370","DOI":"10.1073\/pnas.2436556100","article-title":"L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats","volume":"100","author":"Smriga","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2020.107969_bib222","doi-asserted-by":"crossref","first-page":"444","DOI":"10.7326\/0003-4819-96-4-444","article-title":"Metoclopramide to treat gastroparesis due to diabetes mellitus: a double-blind, controlled trial","volume":"96","author":"Snape","year":"1982","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neuropharm.2020.107969_bib223","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/j.gastro.2016.07.032","article-title":"Protective actions of epithelial 5-hydroxytryptamine 4 receptors in normal and inflamed colon","volume":"151","author":"Spohn","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib224","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1039\/B714374P","article-title":"Crystalline forms and aqueous solubilities of an IBS drug, tegaserod","volume":"10","author":"Srivijaya","year":"2008","journal-title":"CrystEngComm"},{"key":"10.1016\/j.neuropharm.2020.107969_bib225","doi-asserted-by":"crossref","first-page":"106","DOI":"10.33590\/emjgastroenterol\/10314603","article-title":"The versatile role of the vagus nerve in the gastrointestinal tract","volume":"1","author":"Stakenborg","year":"2013","journal-title":"EMJ Gastroenterol."},{"issue":"231","key":"10.1016\/j.neuropharm.2020.107969_bib226","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/003655299750025237","article-title":"Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the domestic\/international gastroenterology surveillance study (DIGEST)","volume":"34","author":"Stanghellini","year":"1999","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib227","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0006-8993(00)03312-6","article-title":"Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo\u2013pituitary axes in vitro and in vivo in male rats","volume":"893","author":"Stanley","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.107969_bib228","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.674","article-title":"Brain serotonin 4 receptor binding is inversely associated with verbal memory recall","volume":"7","author":"Stenb\u00e6k","year":"2017","journal-title":"Brain Behav."},{"key":"10.1016\/j.neuropharm.2020.107969_bib229","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0028-3908(84)90067-4","article-title":"Regulation and function of noradrenaline receptor systems in brain. Psychopharmacological aspects","volume":"23","author":"Sulser","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib230","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1515\/tnsci-2016-0007","article-title":"The serotonergic system and cognitive function","volume":"7","author":"\u0160vob \u0160trac","year":"2016","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib231","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2165\/00002018-199512060-00004","article-title":"A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders","volume":"12","author":"Tack","year":"1995","journal-title":"Drug Saf."},{"key":"10.1016\/j.neuropharm.2020.107969_bib232","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/gut.2008.162404","article-title":"Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives","volume":"58","author":"Tack","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2020.107969_bib233","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1046\/j.1365-2036.2003.01775.x","article-title":"Influence of tegaserod on proximal gastric tone and on the perception of gastric distension","volume":"18","author":"Tack","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2020.107969_bib234","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5056\/jnm.2014.20.1.17","article-title":"The 5-hydroxytryptamine 4 receptor agonist-induced actions and enteric neurogenesis in the gut","volume":"20","author":"Takaki","year":"2014","journal-title":"J. Neurogastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2020.107969_bib235","first-page":"2395","article-title":"Serotonin receptor expression along the dorsal-ventral axis of mouse hippocampus","volume":"367","author":"Tanaka","year":"2012","journal-title":"Phil. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib236","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","article-title":"Pharmacological profile of antidepressants and related compounds at human monoamine transporters","volume":"340","author":"Tatsumi","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib237","first-page":"224","article-title":"Disorders of mood after traumatic brain injury","volume":"3","author":"Taylor","year":"1998","journal-title":"Semin. Clin. Neuropsychiatry"},{"key":"10.1016\/j.neuropharm.2020.107969_bib238","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.neuron.2018.04.030","article-title":"Hippocampal 5-HT input regulates memory formation and schaffer collateral excitation","volume":"98","author":"Teixeira","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.107969_bib239","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s002130050529","article-title":"Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist, RS17017","volume":"135","author":"Terry","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib240","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.pharmthera.2005.12.006","article-title":"5-ht5A receptors as a therapeutic target","volume":"111","author":"Thomas","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2020.107969_bib241","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.2174\/138161206778522029","article-title":"5-HT3 receptors","volume":"12","author":"Thompson","year":"2006","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.neuropharm.2020.107969_bib242","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF03345535","article-title":"Endocrine disturbances in depression","volume":"28","author":"Tichomirowa","year":"2005","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.neuropharm.2020.107969_bib243","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1210\/en.2002-220416","article-title":"Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene","volume":"143","author":"Tjurmina","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib244","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jss.2010.05.002","article-title":"The role of 5-HT3 and 5-HT4 receptors in the adaptive mechanism of colonic transit following the parasympathetic denervation in rats","volume":"171","author":"Tong","year":"2011","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.neuropharm.2020.107969_bib245","first-page":"287","article-title":"The gastrointestinal endocrine system","volume":"122","author":"Track","year":"1980","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.neuropharm.2020.107969_bib246","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/gut.2010.227546","article-title":"Neuronal stimulation with 5-hydroxytryptamine 4 receptor induces anti-inflammatory actions via \u03b17nACh receptors on muscularis macrophages associated with postoperative ileus","volume":"60","author":"Tsuchida","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2020.107969_bib247","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/sj.bjp.0705184","article-title":"5-HT7 receptors mediate the inhibitory effect of 5-HT on peristalsis in the isolated Guinea-pig ileum","volume":"138","author":"Tuladhar","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib248","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/sj.bjp.0703747","article-title":"Pharmacological characterization of the 5-HT receptor-mediated contraction in the mouse isolated ileum","volume":"131","author":"Tuladhar","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib249","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0021-9258(18)66041-7","article-title":"The extimation of 5-hydroxytryptamine (serotonin) in biological tissues","volume":"215","author":"Udenfriend","year":"1955","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2020.107969_bib250","first-page":"1","article-title":"Serotonin receptors, agonists and antagonists","volume":"18","author":"Upadhyay","year":"2003","journal-title":"Indian J. Nucl. Med."},{"key":"10.1016\/j.neuropharm.2020.107969_bib251","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1523\/JNEUROSCI.21-10-03572.2001","article-title":"5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells","volume":"21","author":"Van de Kar","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107969_bib252","series-title":"Handbook of Psychopharmacology: Volume 13 Biology of Mood and Antianxiety Drugs","first-page":"187","article-title":"Amine hypotheses of affective disorders","author":"Van Praag","year":"1978"},{"key":"10.1016\/j.neuropharm.2020.107969_bib253","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/gut.49.6.828","article-title":"Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial","volume":"49","author":"Veysey","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2020.107969_bib254","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/cne.20447","article-title":"Serotonin 5-HT4 receptors and their mRNAs in rat and Guinea pig brain: distribution and effects of neurotoxic lesions","volume":"484","author":"Vilar\u00f3","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib255","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0028-3908(01)00154-X","article-title":"Cloning and characterization of a novel human 5-HT4 receptor variant that lacks the alternatively spliced carboxy terminal exon. RT-PCR distribution in human brain and periphery of multiple 5-HT4 receptor variants","volume":"42","author":"Vilar\u00f3","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.107969_bib256","series-title":"Mental Disorders Affect One in Four People","author":"WHO","year":"2018"},{"key":"10.1016\/j.neuropharm.2020.107969_bib257","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.1078197","article-title":"Synthesis of serotonin by a second tryptophan hydroxylase isoform","volume":"299","author":"Walther","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.107969_bib258","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1176\/ajp.145.7.815","article-title":"The epidemiology of dysthymia in five communities: rates, risks, comorbidity, and treatment","volume":"145","author":"Weissman","year":"1988","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.107969_bib259","doi-asserted-by":"crossref","first-page":"14680","DOI":"10.1038\/s41598-017-13982-0","article-title":"miR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndrome","volume":"7","author":"Wohlfarth","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2020.107969_bib260","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1476-5381.2012.02022.x","article-title":"5-HT(6) receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms","volume":"167","author":"Woods","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib261","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5056\/jnm.2012.18.1.13","article-title":"Psychological Co-morbidity in functional gastrointestinal disorders: epidemiology, mechanisms and management","volume":"18","author":"Wu","year":"2012","journal-title":"J. Neurogastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2020.107969_bib262","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0022-3565(25)39528-5","article-title":"SC-53606, a potent and selective antagonist of 5-hydroxytryptamine4 receptors in isolated rat esophageal tunica muscularis mucosae","volume":"266","author":"Yang","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2020.107969_bib263","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2174\/1570159X1304150831150507","article-title":"The effects of psychological stress on depression","volume":"13","author":"Yang","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib264","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-017-0306-y","article-title":"The role of 5-HT receptors in depression","volume":"10","author":"Yohn","year":"2017","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2020.107969_bib265","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.neures.2011.07.1824","article-title":"Subtype specific roles of serotonin receptors in the spine formation of cortical neurons in vitro","volume":"71","author":"Yoshida","year":"2011","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2020.107969_bib266","doi-asserted-by":"crossref","first-page":"9437","DOI":"10.3748\/wjg.v22.i42.9437","article-title":"Prevalence of depression and anxiety in patients with chronic digestive system diseases: a multicenter epidemiological study","volume":"22","author":"Zhang","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2020.107969_bib267","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2004.12.014","article-title":"Loss of function mutation in tryptophan hydroxylase-2 identified in unipolar major depression","volume":"45","author":"Zhang","year":"2005","journal-title":"Neuron"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820300356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820300356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:00:30Z","timestamp":1758438030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820300356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":268,"alternative-id":["S0028390820300356"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107969","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of serotonin 4 receptor for chronic depression and its associated comorbidity in the gut","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107969"}}